Millendo Therapeutics SAS
1 clinical trials · Sponsor
◉ Watch Millendo Therapeutics SAS
| Record | Firm | Date |
|---|---|---|
| Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome (NCT03790865) | Millendo Therapeutics SAS | 2019-03-25 |
Track Millendo Therapeutics SAS automatically
Every clearance here is in the API, with alerts when new ones post.